• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞衍生的外泌体将 miR-223 递送至上皮性卵巢癌细胞以引发耐药表型。

Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.

机构信息

Department of Gynecologic Oncology and Central Laboratory, Fourth Affiliated Hospital of Jiangsu University, 20 Zhengdong Road, Zhenjiang, Jiangsu, 212001, People's Republic of China.

Reproductive Sciences Institute, Jiangsu University, Zhenjiang, 212001, Jiangsu, China.

出版信息

J Exp Clin Cancer Res. 2019 Feb 15;38(1):81. doi: 10.1186/s13046-019-1095-1.

DOI:10.1186/s13046-019-1095-1
PMID:30770776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6377760/
Abstract

BACKGROUND

How exosomal microRNAs (miRNAs) derived from macrophages contribute to the development of drug resistance in the context of the hypoxic tumor microenvironment in epithelial ovarian cancer (EOC) remains poorly understood.

METHODS

The miRNA levels were detected by qRT-PCR. Protein levels of HIF-1α, CD163 and PTEN-PI3K/AKT pathway were assessed by Western blot (WB) and Immunohistochemistry (IHC). Exosomes were isolated, and then confirmed by Transmission electron microscopy (TEM), Nanoparticle Tracking Analysis (NTA) and WB. Internalization of macrophages-secreted exosomes in EOC cells was detected by Confocal microscope. Subsequently, Dual-luciferase reporter assay verified PTEN was the target of miR-223. Gain- and loss-of-function experiments, rescue experiments, and SKOV3 xenograft models were performed to uncover the underlying mechanisms of miR-223 and PTEN-PI3K/AKT pathway, as well as the exosomal miR-223 in inducing multidrug resistance in vitro and in vivo.

RESULTS

Here, we showed hypoxic EOC cells triggered macrophages recruitment and induced macrophages into a tumor-associated macrophage (TAM)-like phenotype; exosomes derived from hypoxic macrophages enhanced the malignant phenotype of EOC cells, miR-223 was enriched in exosomes released from macrophages under hypoxia, which could be transferred to the co-cultivated EOC cells, accompanied by enhanced drug resistant of EOC cells. Besides, results from a functional assay revealed that exosomal miR-223 derived from macrophages promoted the drug resistance of EOC cells via the PTEN-PI3K/AKT pathway both in vivo and in vitro. Furthermore, patients with high HIF-1a expression had statistically higher CD163+ cell infiltration and intertumoral levels of miR-223. Finally, circulating exosomal miR-223 levels were closely related to the recurrence of EOC.

CONCLUSIONS

These data indicate a unique role of exosomal miR-223 in the cross-talk between macrophages and EOC cells in chemotherapy resistance, through a novel exosomal miR-223/PTEN-PI3K/AKT signaling pathway.

摘要

背景

在缺氧的卵巢癌细胞(EOC)肿瘤微环境中,巨噬细胞来源的外泌体 miRNA(miRNA)如何导致耐药性的发展尚不清楚。

方法

通过 qRT-PCR 检测 miRNA 水平。通过 Western blot(WB)和免疫组织化学(IHC)评估 HIF-1α、CD163 和 PTEN-PI3K/AKT 通路的蛋白水平。分离外泌体,然后通过透射电子显微镜(TEM)、纳米颗粒跟踪分析(NTA)和 WB 进行确认。通过共聚焦显微镜检测巨噬细胞分泌的外泌体在 EOC 细胞中的内化。随后,双荧光素酶报告基因实验验证 PTEN 是 miR-223 的靶基因。进行 gain-和 loss-of-function 实验、挽救实验和 SKOV3 异种移植模型,以揭示 miR-223 和 PTEN-PI3K/AKT 通路以及外泌体 miR-223 在体外和体内诱导多药耐药的潜在机制。

结果

在这里,我们表明缺氧的 EOC 细胞触发巨噬细胞募集并诱导巨噬细胞向肿瘤相关巨噬细胞(TAM)样表型;来自缺氧巨噬细胞的外泌体增强了 EOC 细胞的恶性表型,miR-223 在缺氧条件下从巨噬细胞释放的外泌体中富集,可转移到共培养的 EOC 细胞中,同时增强 EOC 细胞的耐药性。此外,功能测定结果表明,来自巨噬细胞的外泌体 miR-223 通过 PTEN-PI3K/AKT 通路在体内和体外均促进了 EOC 细胞的耐药性。此外,HIF-1a 表达水平高的患者具有统计学上更高的 CD163+细胞浸润和肿瘤间 miR-223 水平。最后,循环外泌体 miR-223 水平与 EOC 的复发密切相关。

结论

这些数据表明外泌体 miR-223 在巨噬细胞和 EOC 细胞之间的化疗耐药性相互作用中具有独特的作用,通过一种新的外泌体 miR-223/PTEN-PI3K/AKT 信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/5ae1957784a3/13046_2019_1095_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/a90bfe330615/13046_2019_1095_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/eb89b17e51da/13046_2019_1095_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/b244317f8f7e/13046_2019_1095_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/7d4bc75b8964/13046_2019_1095_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/1be8692cac5c/13046_2019_1095_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/fdb220d3aa90/13046_2019_1095_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/5ae1957784a3/13046_2019_1095_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/a90bfe330615/13046_2019_1095_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/eb89b17e51da/13046_2019_1095_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/b244317f8f7e/13046_2019_1095_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/7d4bc75b8964/13046_2019_1095_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/1be8692cac5c/13046_2019_1095_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/fdb220d3aa90/13046_2019_1095_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/6377760/5ae1957784a3/13046_2019_1095_Fig7_HTML.jpg

相似文献

1
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.巨噬细胞衍生的外泌体将 miR-223 递送至上皮性卵巢癌细胞以引发耐药表型。
J Exp Clin Cancer Res. 2019 Feb 15;38(1):81. doi: 10.1186/s13046-019-1095-1.
2
TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)刺激的巨噬细胞通过外泌体介导的微小RNA转运抑制上皮性卵巢癌转移。
Cancer Lett. 2017 May 1;393:60-67. doi: 10.1016/j.canlet.2017.02.009. Epub 2017 Feb 16.
3
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.外泌体 miRNA 通过靶向 Cav1/p-gp/M2 型巨噬细胞轴赋予卵巢癌细胞化疗耐药性。
EBioMedicine. 2018 Dec;38:100-112. doi: 10.1016/j.ebiom.2018.11.004. Epub 2018 Nov 25.
4
Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype.缺氧上皮性卵巢癌细胞来源的外泌体将 microRNAs 递送至巨噬细胞并引发促进肿瘤的表型。
Cancer Lett. 2018 Oct 28;435:80-91. doi: 10.1016/j.canlet.2018.08.001. Epub 2018 Aug 8.
5
Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization.源自缺氧上皮性卵巢癌的外泌体传递微小RNA-940以诱导巨噬细胞M2极化。
Oncol Rep. 2017 Jul;38(1):522-528. doi: 10.3892/or.2017.5697. Epub 2017 Jun 6.
6
Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages.上皮性卵巢癌分泌的外泌体 miR-222-3p 诱导肿瘤相关巨噬细胞极化。
Oncotarget. 2016 Jul 12;7(28):43076-43087. doi: 10.18632/oncotarget.9246.
7
Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.外泌体 microRNA-32-5p 通过 PI3K/Akt 通路诱导肝癌多药耐药。
J Exp Clin Cancer Res. 2018 Mar 12;37(1):52. doi: 10.1186/s13046-018-0677-7.
8
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.肿瘤相关巨噬细胞衍生的miR-21通过外泌体转移赋予胃癌细胞顺铂耐药性。
J Exp Clin Cancer Res. 2017 Apr 13;36(1):53. doi: 10.1186/s13046-017-0528-y.
9
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.外泌体 miR-99a-5p 在卵巢癌患者血清中升高,并通过增加邻近腹膜间皮细胞中纤连蛋白和 vitronectin 的表达促进癌细胞侵袭。
BMC Cancer. 2018 Nov 5;18(1):1065. doi: 10.1186/s12885-018-4974-5.
10
Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3.低氧肺腺癌衍生的外泌体 miR-1290 通过靶向 SOCS3 诱导 M2 巨噬细胞极化。
Cancer Med. 2023 Jun;12(11):12639-12652. doi: 10.1002/cam4.5954. Epub 2023 Apr 20.

引用本文的文献

1
Cracking the code: predicting tumor microenvironment enabled chemoresistance with machine learning in the human tumoroid models.破解密码:在人类肿瘤类器官模型中利用机器学习预测肿瘤微环境介导的化疗耐药性。
NPJ Biomed Innov. 2025;2(1):28. doi: 10.1038/s44385-025-00032-y. Epub 2025 Aug 19.
2
Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance.卵巢癌化疗耐药中的信号网络与微小RNA相互作用
J Ovarian Res. 2025 Aug 14;18(1):185. doi: 10.1186/s13048-025-01770-8.
3
Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques.

本文引用的文献

1
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.C/EBPβ 通过重编程 H3K79 甲基化增强卵巢癌细胞的铂耐药性。
Nat Commun. 2018 Apr 30;9(1):1739. doi: 10.1038/s41467-018-03590-5.
2
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.缺氧诱导的外泌体促进更具侵袭性和耐药性的卵巢癌表型:连接 STAT3/Rab 蛋白的新机制。
Oncogene. 2018 Jul;37(28):3806-3821. doi: 10.1038/s41388-018-0189-0. Epub 2018 Apr 11.
3
Metabolic features of macrophages in inflammatory diseases and cancer.
卵巢癌中的外泌体:对耐药性的影响及表面增强拉曼散射检测技术的进展
J Pharm Anal. 2025 Jul;15(7):101170. doi: 10.1016/j.jpha.2024.101170. Epub 2024 Dec 18.
4
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer (HGSC) cells, carcinoma associated fibroblasts, and macrophages.肿瘤样模型再现了高级别浆液性卵巢癌(HGSC)细胞、癌相关成纤维细胞和巨噬细胞的临床相关表型。
Res Sq. 2025 Jun 19:rs.3.rs-6614892. doi: 10.21203/rs.3.rs-6614892/v1.
5
T cell-derived small extracellular vesicles in cancer-immune interactions.癌症免疫相互作用中T细胞衍生的小细胞外囊泡
Cancer Immunol Immunother. 2025 Jun 25;74(8):252. doi: 10.1007/s00262-025-04109-w.
6
Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review.解析M2肿瘤相关巨噬细胞在卵巢癌动态变化中的作用:一项系统综述
J Transl Med. 2025 Jun 3;23(1):623. doi: 10.1186/s12967-025-06643-8.
7
Characterization of Extrachromosomal Circular DNA in Primary and Cisplatin-Resistant High-Grade Serous Ovarian Cancer.原发性及顺铂耐药高级别浆液性卵巢癌中染色体外环状DNA的特征分析
Genes (Basel). 2025 Apr 29;16(5):517. doi: 10.3390/genes16050517.
8
Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions.外泌体介导的癌症化疗耐药性:机制、治疗意义及未来方向
Biomolecules. 2025 May 8;15(5):685. doi: 10.3390/biom15050685.
9
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements.肿瘤微环境在卵巢癌转移及临床进展中的作用
J Transl Med. 2025 May 14;23(1):539. doi: 10.1186/s12967-025-06508-0.
10
Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential.癌症中巨噬细胞衍生的外泌体:一把具有治疗潜力的双刃剑。
J Nanobiotechnology. 2025 Apr 26;23(1):319. doi: 10.1186/s12951-025-03321-1.
炎症性疾病和癌症中巨噬细胞的代谢特征
Cancer Lett. 2018 Jan 28;413:46-58. doi: 10.1016/j.canlet.2017.10.044. Epub 2017 Nov 1.
4
Exercise-dependent regulation of the tumour microenvironment.运动依赖性的肿瘤微环境调控。
Nat Rev Cancer. 2017 Sep 25;17(10):620-632. doi: 10.1038/nrc.2017.78.
5
Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.致癌性酪氨酸磷酸酶的治疗靶点
Cancer Res. 2017 Nov 1;77(21):5701-5705. doi: 10.1158/0008-5472.CAN-17-1510. Epub 2017 Aug 30.
6
Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs.疱疹病毒通过病毒微小RNA的外泌体转移塑造肿瘤微环境。
PLoS Pathog. 2017 Aug 24;13(8):e1006524. doi: 10.1371/journal.ppat.1006524. eCollection 2017 Aug.
7
HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells.缺氧条件下HIF-1介导的外泌体产生对肾小管细胞具有保护作用。
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F906-F913. doi: 10.1152/ajprenal.00178.2017. Epub 2017 Jul 5.
8
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.FGFR1酪氨酸激酶结构域的突变或PTEN的失活与FGFR1驱动的白血病/淋巴瘤中对FGFR抑制剂的获得性耐药有关。
Int J Cancer. 2017 Nov 1;141(9):1822-1829. doi: 10.1002/ijc.30848. Epub 2017 Jul 28.
9
Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.M2样肿瘤相关巨噬细胞中CECR1的激活促进旁分泌刺激介导的胶质肿瘤进展。
Neuro Oncol. 2017 May 1;19(5):648-659. doi: 10.1093/neuonc/now251.
10
Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.缺氧肺癌分泌的外泌体miR-23a通过靶向脯氨酰羟化酶和紧密连接蛋白ZO-1增加血管生成和血管通透性。
Oncogene. 2017 Aug 24;36(34):4929-4942. doi: 10.1038/onc.2017.105. Epub 2017 Apr 24.